Divis Laboratories Ltd | DIVI - Ebit

Stock Price
6,758.00
Daily Change
-163.50 -2.36%
Monthly
7.38%
Yearly
7.62%
Q2 Forecast
6,560.86

Divis Laboratories Ltd reported INR7.72B in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Alaunos Therapeutics USD -1.19M 148K Sep/2025
Aurobindo Pharma INR 12.43B 1.49B Dec/2025
Avita Medical AUD -10.39M 1.72M Dec/2025
Dianthus Therapeutics USD -69.54M 29.25M Dec/2025
Divis Laboratories Ltd INR 7.72B 30M Dec/2025
Ionis Pharmaceuticals USD -118M 97M Mar/2026
IQVIA Holdings USD 565M 2.11B Mar/2026
Lupin INR 17.24B 1.72B Mar/2026
Moderna USD -1.39B 531M Mar/2026
Organon & Co USD -27M 415M Dec/2025
Revvity USD 82.77M 63.06M Mar/2026
Tectonic Therapeutic USD -21.52M 374K Dec/2025
Tilray USD -20.01M 9.34M Sep/2025
Viatris USD -20.2M 137.3M Mar/2026
Xeris Pharmaceuticals USD 16.77M 8.88M Dec/2025